Antiadhesion Molecule Therapy in Inflammatory Bowel Disease
Open Access
- 1 July 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 8 (4) , 291-300
- https://doi.org/10.1097/00054725-200207000-00009
Abstract
Summary. Adhesion molecules regulate the influx of leukocytes in normal and inflamed gut. Some of these molecules such as MadCAM-1 are specific for the gastroiKeywords
This publication has 50 references indexed in Scilit:
- Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamineGastroenterology, 2001
- A randomized, placebo-controlled trial of an antisense ICAM-1 inhibitor (ISIS 2302) in steroid-dependent Crohn's disease showed clinical improvement at high serum levelsGastroenterology, 2001
- Double-blinded, randomized, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS 2302 (ICAM-1 antisense) in active, steroid-dependent crohn's diseaseGastroenterology, 2000
- An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC)Gastroenterology, 2000
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- β2 Integrin/ICAM Expression in Crohn's DiseaseClinical Immunology and Immunopathology, 1998
- Molecular Mechanisms of Lymphocyte Homing to Peripheral Lymph NodesThe Journal of Experimental Medicine, 1998
- Human Intestinal B‐Cell Blasts and Plasma Cells Express the Mucosal Homing Receptor Integrin α4β7Scandinavian Journal of Immunology, 1995
- Adhesion Molecule Expression on Vascular Endothelium and Nitroblue Tetrazolium Reducing Activity in Human Colonic MucosaScandinavian Journal of Gastroenterology, 1995
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994